Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Axogen, Inc. Director's Dealing 2015

Jun 5, 2015

32414_dirs_2015-06-05_71c99c76-b5d5-4dc7-a11d-41c8af6663bf.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AxoGen, Inc. (AXGN)
CIK: 0000805928
Period of Report: 2015-06-03

Reporting Person: Mandato Joseph M (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2015-06-03 Common Stock P 6500 $3.10 Acquired 50000 Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 1376392 Indirect

Footnotes

F1: The shares are owned by De Novo Ventures II, L.P. ("DNV II"). De Novo Management II, LLC is the sole general partner of DNV II. The reporting person is a managing member of De Novo Management II, LLC. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein.